Literature DB >> 9744537

Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin.

M K Smith1, C S Trempus, S K Gilmour.   

Abstract

Ornithine decarboxylase (ODC) is aberrantly regulated in tumor cells and results in high basal levels of ODC and polyamines in many epithelial tumors. To determine if elevated ODC/polyamine levels can co-operate with a mutant Ha-ras gene in mouse skin tumorigenesis, double transgenic mice were generated by breeding K6/ODC transgenic mice with TG.AC v-Ha-ras transgenic mice. A K6 keratin promoter drives the ODC transgene in K6/ ODC transgenic mice, which results in elevated ODC/ polyamine levels directed to the outer root sheath cells of hair follicles. TG.AC transgenic mice carry a v-Ha-ras transgene while still retaining two normal c-Ha-ras alleles. Transgenic mice that possess only the K6/ODC or the v-Ha-ras transgene did not develop tumors unless treated with either a carcinogen or a tumor promoter, respectively. However, a high percentage of double transgenic mice possessing both the K6/ODC and v-Ha-ras transgenes developed spontaneous tumors. All tumors were well-differentiated keratoacanthomas, some of which progressed to carcinomas within 2 months. The development and the maintenance of these ODC/ras tumors was ODC-dependent since alpha-difluoromethylornithine (DFMO), a specific ODC inhibitor, prevented the formation and caused the regression of these tumors. These findings indicate that ODC overexpression and an activated Ha-ras are sufficient to produce a high rate of malignant transformation in an animal model. The ODC/ras double transgenic mouse provides a simple in vivo model without the use of chemical carcinogens or tumor promoters in which to test downstream effectors that play a key role in mediating the development of epithelial tumors resulting from the cooperation between ODC and v-Ha-ras.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9744537     DOI: 10.1093/carcin/19.8.1409

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  27 in total

1.  Polyamines regulate gap junction communication in connexin 43-expressing cells.

Authors:  L Shore; P McLean; S K Gilmour; M B Hodgins; M E Finbow
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

2.  Elevated ornithine decarboxylase activity promotes skin tumorigenesis by stimulating the recruitment of bulge stem cells but not via toxic polyamine catabolic metabolites.

Authors:  Candace S Hayes; Karen DeFeo-Mattox; Patrick M Woster; Susan K Gilmour
Journal:  Amino Acids       Date:  2013-07-25       Impact factor: 3.520

3.  B23 is a downstream target of polyamine-modulated CK2.

Authors:  Kathryn Lawson; Laura Larentowicz; Lisa Laury-Kleintop; Susan K Gilmour
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

4.  A prolonged and exaggerated wound response with elevated ODC activity mimics early tumor development.

Authors:  Candace S Hayes; Karen Defeo; Hong Dang; Carol S Trempus; Rebecca J Morris; Susan K Gilmour
Journal:  Carcinogenesis       Date:  2011-07-05       Impact factor: 4.944

5.  Cytoplasmic accumulation of the RNA-binding protein HuR stabilizes the ornithine decarboxylase transcript in a murine nonmelanoma skin cancer model.

Authors:  Shannon L Nowotarski; Lisa M Shantz
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

6.  S-adenosylmethionine decarboxylase overexpression inhibits mouse skin tumor promotion.

Authors:  Chenxu Shi; Timothy K Cooper; Diane E McCloskey; Adam B Glick; Lisa M Shantz; David J Feith
Journal:  Carcinogenesis       Date:  2012-05-19       Impact factor: 4.944

7.  Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment.

Authors:  Candace S Hayes; Allyson C Shicora; Martin P Keough; Adam E Snook; Mark R Burns; Susan K Gilmour
Journal:  Cancer Immunol Res       Date:  2013-10-07       Impact factor: 11.151

8.  Targeting ornithine decarboxylase impairs development of MYCN-amplified neuroblastoma.

Authors:  Robert J Rounbehler; Weimin Li; Mark A Hall; Chunying Yang; Mohammad Fallahi; John L Cleveland
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

9.  Elevated ornithine decarboxylase levels activate ataxia telangiectasia mutated-DNA damage signaling in normal keratinocytes.

Authors:  Gang Wei; Karen DeFeo; Candace S Hayes; Patrick M Woster; Laura Mandik-Nayak; Susan K Gilmour
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

Review 10.  Disrupting polyamine homeostasis as a therapeutic strategy for neuroblastoma.

Authors:  Nicholas F Evageliou; Michael D Hogarty
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.